BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ekman S, Griesinger F, Baas P, Chao D, Chouaid C, O'donnell JC, Penrod JR, Daumont M, Lacoin L, Mckenney A, Khovratovich M, Munro RE, Durand-zaleski I, Johnsen SP. I-O Optimise: a novel multinational real-world research platform in thoracic malignancies. Future Oncology 2019;15:1551-63. [DOI: 10.2217/fon-2019-0025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Carroll R, Bortolini M, Calleja A, Munro R, Kong S, Daumont MJ, Penrod JR, Lakhdari K, Lacoin L, Cheung WY. Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: a Canadian population-based real-world analysis. BMC Cancer 2022;22:255. [PMID: 35264135 DOI: 10.1186/s12885-022-09342-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Soares M, Antunes L, Redondo P, Borges M, Grimson F, Hermans R, Chaib C, Lacoin L, Juarez-Garcia A, Daumont MJ, Penrod JR, Bento MJ, Gonçalves FR. Small cell lung cancer treatment and survival in Portugal: A retrospective analysis from the I-O Optimise initiative. Eur J Cancer Care (Engl) 2021;:e13496. [PMID: 34288191 DOI: 10.1111/ecc.13496] [Reference Citation Analysis]
3 Joachim C, Vestris M, Marous M, Almont T, Ulric-Gervaise S, Dramé M, Contaret C, Smith-Ravin J, Escarmant P, Sylvestre E, Véronique-Baudin J. Modeling the future of cancer registration and research: The Martinique Cancer Data Hub Platform. J Glob Health 2020;10:020352. [PMID: 33110548 DOI: 10.7189/jogh.10.020352] [Reference Citation Analysis]
4 Ekman S, Horvat P, Rosenlund M, Kejs AM, Patel D, Juarez-Garcia A, Lacoin L, Daumont MJ, Penrod JR, Brustugun OT, Sørensen JB. Epidemiology and Survival Outcomes for Patients With NSCLC in Scandinavia in the Preimmunotherapy Era: A SCAN-LEAF Retrospective Analysis From the I-O Optimise Initiative. JTO Clin Res Rep 2021;2:100165. [PMID: 34590017 DOI: 10.1016/j.jtocrr.2021.100165] [Reference Citation Analysis]
5 Baas P, Daumont MJ, Lacoin L, Penrod JR, Carroll R, Venkatesan S, Ubhi H, Calleja A, Snee M. Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017: A nationwide CAS registry analysis from the I-O Optimise initiative. Lung Cancer 2021;162:185-93. [PMID: 34823894 DOI: 10.1016/j.lungcan.2021.11.001] [Reference Citation Analysis]
6 Snee M, Cheeseman S, Thompson M, Riaz M, Sopwith W, Lacoin L, Chaib C, Manley Daumont M, Penrod JR, O'Donnell JC, Hall G. Trends in the prescription of systemic anticancer therapy and mortality among patients with advanced non-small cell lung cancer: a real-world retrospective observational cohort study from the I-O optimise initiative. BMJ Open 2021;11:e043442. [PMID: 33941627 DOI: 10.1136/bmjopen-2020-043442] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Berghmans T, Lievens Y, Aapro M, Baird AM, Beishon M, Calabrese F, Dégi C, Delgado Bolton RC, Gaga M, Lövey J, Luciani A, Pereira P, Prosch H, Saar M, Shackcloth M, Tabak-Houwaard G, Costa A, Poortmans P. European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Lung cancer. Lung Cancer 2020;150:221-39. [PMID: 33227525 DOI: 10.1016/j.lungcan.2020.08.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
8 Soares M, Antunes L, Redondo P, Borges M, Hermans R, Patel D, Grimson F, Munro R, Chaib C, Lacoin L, Daumont M, Penrod JR, O'Donnell JC, Bento MJ, Rocha Gonçalves F. Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative. BMC Pulm Med 2020;20:240. [PMID: 32912174 DOI: 10.1186/s12890-020-01270-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sørensen JB, Horvat P, Rosenlund M, Kejs AM, Patel D, Juarez-Garcia A, Lacoin L, Daumont MJ, Penrod JR, O'Donnell JC, Brustugun OT, Ekman S. Initial treatment and survival in Danish patients diagnosed with non-small-cell lung cancer (2005-2015): SCAN-LEAF study. Future Oncol 2021. [PMID: 34784783 DOI: 10.2217/fon-2021-0746] [Reference Citation Analysis]
10 Soares M, Antunes L, Redondo P, Borges M, Hermans R, Patel D, Grimson F, Munro R, Chaib C, Lacoin L, Daumont M, Penrod JR, O'Donnell JC, Bento MJ, Gonçalves FR. Treatment and outcomes for early non-small-cell lung cancer: a retrospective analysis of a Portuguese hospital database. Lung Cancer Manag 2021;10:LMT46. [PMID: 34084212 DOI: 10.2217/lmt-2020-0028] [Reference Citation Analysis]
11 Snee M, Cheeseman S, Thompson M, Riaz M, Sopwith W, Lacoin L, Chaib C, Daumont MJ, Penrod JR, Hall G. Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative. BMJ Open 2021;11:e046396. [PMID: 34526333 DOI: 10.1136/bmjopen-2020-046396] [Reference Citation Analysis]
12 Helanterä I, Snyder J, Åsberg A, Cruzado JM, Bell S, Legendre C, Tedesco-silva H, Barcelos GT, Geissbühler Y, Prieto L, Christian JB, Scalfaro E, Dreyer NA. Demonstrating Benefit-Risk Profiles of Novel Therapeutic Strategies in Kidney Transplantation: Opportunities and Challenges of Real-World Evidence. Transpl Int 2022;35:10329. [DOI: 10.3389/ti.2022.10329] [Reference Citation Analysis]